The Conavi Team

Senior Management

Thomas Looby

Chief Executive Officer

Photo of Aman Thind

Amandeep Thind

Chief Technology Officer

Photo of Stefano Picone

Stefano Picone

Chief Financial Officer

Photo of Sumeet Dham

Sumeet Dham

Vice President, Research & Development

Photo of Bob Skidmore

Robert Skidmore

Vice President, Operations

Photo of Travis More

Travis More

Vice President, Human Resources

Photo of Julie Dunham

Julie Dunham

Director, Product Management & Marketing

Board of Directors

Thomas Looby

Chief Executive Officer at Conavi Medical

Photo of Aaron Davidson

Aaron Davidson

Board Chair, Former SVP Corporate Development at Profound Medical

Anthony Giovinazzo

Board Member, Former CEO at Cynapsus Therapeutics

Cathy Steiner

Board Member, Managing Director at Origin Merchant Partners

Photo of Susan Allen

Susan Allen

Board Member, Audit Committee Chair, Former Audit Partner PwC

Photo of Craig Podolsky

Craig Podolsky

Board Member, Partner at CPOINT Capital

Photo of Robert Mitchell

Robert D.Mitchell

Board Member, Governance and HR Committee Chair, Former CEO at Nellix and SVP at Cook Medical

The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. The Novasight Hybrid System is cleared for sale in the following jurisdictions (regulatory approvals referenced): • United States: FDA 510(k) clearance (K172258) • Canada: Health Canada medical device license (102500) • Japan: PMDA medical device license (catheter: 30200BZX00040000, console + PIM: 30200BZX00039000) ISI: conavi.com/novasight/isi Accessibility Policy: conavi.com/novasight/accessibility-policy